This opportunity is no longer accepting applications.
grant RFA-HG-23-018

Investigator-Initiated Research in Genomics and Health Equity (R21 Clinical Trial Optional)

This grant opportunity supports research in genomics and health equity, aiming to use genomics to improve public health fairly. It encourages innovative, broad research with diverse perspectives in genomics. New or Early Stage Investigators from diverse backgrounds are especially encouraged to apply. The R21 grant assists small projects that can be completed quickly with limited funding and he…

The purpose of this initiative is to support investigator-initiated research in genomics and health equity, with the ultimate goal of developing approaches, generating and disseminating data, and implementing metrics or interventions that will advance the equitable use of genomics to improve hea…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Human Genome Research Institute

Awards & funding

Award Ceiling: $200,000
Award Amount: $200,000

Dates

Submission Deadline: July 8, 2025
Open for Submission: June 5, 2023
Application Window Closes: July 8, 2025
Opportunity Released: June 5, 2023

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.